ClinicalTrials.Veeva

Menu

Artificial Intelligence for Automated Diagnosis of Breast Cancer (AICAMAMMELLA)

R

Regina Elena Cancer Institute

Status

Enrolling

Conditions

Breast Cancer Diagnosis

Treatments

Diagnostic Test: Breast digital tomosynthesis

Study type

Observational

Funder types

Other

Identifiers

NCT05858762
RS1414/20

Details and patient eligibility

About

Mammography is a two-dimensional imaging technique which involves the tissues overlapping under the projective image; dense glandular tissue above or below the lesion can reduce the visibility of the lesion.

The trouble could be the interpretation of the image obtained which may lead to the inability to visualize a fist stage cancer and the probability that to a healthy person will be diagnosed a pathology that is not present (false positive). The introduction of an almost three-dimensional technique imaging called breast digital tomosynthesis (DBT) can overcome most limitations. In the last 5 years image analysis methods based on Artificial Intelligence (, AI) have also been massively introduced in breast cancer detection. The study is a prospective observational study based on Artificial intelligence whose the mail goal is to develop a method to identify a lesion.

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who refer to the Regina Elena for diagnostic mammography tests
  • Informed consent

Exclusion criteria

  • presence of prostheses, artifacts, outcomes of a study in the breast intervention under the study

Trial contacts and locations

2

Loading...

Central trial contact

Valeria Landoni

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems